Thomas Mccarthy
Founder bij Pathios Therapeutics Ltd.
Profiel
Thomas Mccarthy founded Pathios Therapeutics Ltd.
in 2017, where he is working as Executive Chairman from 2017.
Mr. Mccarthy also founded Grey Wolf Therapeutics Ltd., where he worked as Executive Chairman.
Mr. Mccarthy also currently works at Orbit Discovery Ltd., as Chairman and Brandon Capital Partners Pty Ltd., as Venture Partner from 2015.
Mr. Mccarthy also formerly worked at Spinifex Pharmaceuticals Pty Ltd., as CEO, Director & Managing Director from 2006 to 2015 and Starpharma Holdings Ltd., as Vice President-Drug Development.
Mr. Mccarthy received his undergraduate degree in 1989 from Monash University and doctorate degree in 1993 from Monash University.
Actieve functies van Thomas Mccarthy
Bedrijven | Functie | Begin |
---|---|---|
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | Chairman | - |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom. | Founder | - |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Founder | 01-01-2017 |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01-01-2015 |
Eerdere bekende functies van Thomas Mccarthy
Bedrijven | Functie | Einde |
---|---|---|
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Chief Executive Officer | - |
STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | - |
Opleiding van Thomas Mccarthy
Monash University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
STARPHARMA HOLDINGS LIMITED | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Health Technology |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | Health Technology |
Grey Wolf Therapeutics Ltd.
Grey Wolf Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom. | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |